Arcus Biosciences, Inc.
USD31.08
+0.08 (+0.26%)
CEO
Terry J. Rosen
IPO Date
2018-03-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Open
$31.10
Prev. Close
$31.00
Day Low
$30.48
Day High
$31.25
52W Low
$7.92
52W High
$31.44
Market Cap
$3.13B
Volume
1.19M
| -4.7 |
| 31 Dec 2023 | FY | 100.0% | -262.4% | -66.5% | -28.0% | 0.02 | 4.52 | -4.6 |
| 31 Dec 2022 | FY | 100.0% | -238.4% | -40.6% | -19.9% | 0.18 | 5.52 | -5.6 |
| 31 Dec 2021 | FY | 100.0% | 13.8% | 6.3% | 3.3% | 0.14 | 7.60 | 53.0 |
| 31 Dec 2020 | FY | 100.0% | -157.7% | -24.5% | -15.9% | 0.04 | 6.05 | -11.6 |
| 31 Dec 2019 | FY | 100.0% | -564.7% | -51.7% | -41.7% | 0.00 | 8.49 | -5.2 |
| 31 Dec 2018 | FY | 100.0% | -593.7% | -21.1% | -18.0% | 0.00 | 15.29 | -7.5 |
| 31 Dec 2017 | FY | 100.0% | -3756.7% | -34.5% | -27.9% | 0.00 | 13.90 | -7.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -18.1% | -16.4% | 0.00 | 17.98 | -23.2 |
| -6.5 |
| 30 Sept 2025 | Q3 | 92.3% | -519.2% | -31.0% | -13.9% | 0.25 | 3.65 | -2.7 |
| 30 Jun 2025 | Q2 | 100.0% | -5.0% | -1.5% | -0.7% | 0.20 | 4.50 | -27.0 |
| 31 Mar 2025 | Q1 | 100.0% | -400.0% | -21.1% | -9.7% | 0.11 | 5.37 | -1.7 |
| 31 Dec 2024 | Q4 | 100.0% | -361.5% | -19.4% | -8.2% | 0.12 | 4.50 | -3.6 |
| 30 Sept 2024 | Q3 | 100.0% | -191.7% | -16.3% | -7.3% | 0.10 | 5.24 | -3.8 |
| 30 Jun 2024 | Q2 | 100.0% | -238.5% | -14.6% | -7.8% | 0.02 | 5.14 | -3.7 |
| 31 Mar 2024 | Q1 | 100.0% | -2.8% | -0.6% | -0.3% | 0.02 | 5.22 | -99.6 |
| 31 Dec 2023 | Q4 | 100.0% | -261.3% | -17.5% | -7.4% | 0.02 | 4.52 | -4.4 |